Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Mar 16, 2015
Clinical News

Auryxia ferric citrate: Additional Phase III data

BioCentury | Apr 15, 2013
Clinical News

RenaGel phosphate binder data

BioCentury | Feb 4, 2013
Clinical News

Zerenex ferric citrate: Phase III data

BioCentury | Aug 22, 2011
Company News

Fresenius, Nabi deal

BioCentury | Dec 6, 2010
Clinical News

Zerenex ferric citrate: Phase III data

BioCentury | Dec 1, 2010
Clinical News

Keryx's Zerenex meets hyperphosphatemia endpoint

BioCentury | Nov 9, 2009
Regulation

Dry Run for Bundling

BioCentury | Dec 22, 2008
Clinical News

PhosLo: Post-marketing study data

Items per page:
1 - 10 of 52